TACI/TNFRSF13B/CVID Antibody - BSA Free, Novus Biologicals™
Manufacturer: Novus Biologicals
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NBP176779-Each-of-1 | In Stock | ₹ 44,455.50 |
NBP176779 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,455.50
GST (18%): ₹ 8,001.99
Total Price: ₹ 52,457.49
Antigen
TACI/TNFRSF13B/CVID
Classification
Polyclonal
Conjugate
Unconjugated
Formulation
PBS with 0.02% Sodium Azide
Gene Alias
CD267, CD267 antigen, CVID, CVID2, FLJ39942, MGC133214, TACIMGC39952, TNFRSF14B, Transmembrane activator and CAML interactor, tumor necrosis factor receptor 13B, tumor necrosis factor receptor superfamily member 13B, tumor necrosis factor receptor superfamily, member 13B
Host Species
Rabbit
Purification Method
Affinity Purified
Regulatory Status
RUO
Primary or Secondary
Primary
Target Species
Human
Isotype
IgG
Applications
Western Blot, ELISA, Immunocytochemistry, Immunofluorescence
Concentration
1 mg/mL
Dilution
Western Blot 5 μg/mL, ELISA 1:100-1:2000, Immunocytochemistry/Immunofluorescence 2 μg/mL
Gene Accession No.
NP_036584
Gene Symbols
TNFRSF13B
Immunogen
Antibody was raised against a synthetic peptide mapping at the amino terminus of human TACI. The immunogen is located within the first 50 amino acids of TACI. Amino Acid Squence: SGLGRSRRGGRSRVD
Quantity
0.1 mg
Research Discipline
Apoptosis, Signal Transduction
Gene ID (Entrez)
23495
Content And Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Related Products
Description
- TACI/TNFRSF13B/CVID Polyclonal specifically detects TACI/TNFRSF13B/CVID in Human samples
- It is validated for Western Blot, ELISA, Immunocytochemistry/Immunofluorescence.